Predictors and Prevalence of Pain and Its Management in Four Regional Cancer Hospitals in India

Overview

Journal J Glob Oncol

Specialty Oncology

Date 2018 Sep 23

PMID 30241192

Citations 15

Authors

Katherine E Doyle

Shatha K El Nakib

M R Rajagopal

Sunil Babu

Geeta Joshi

Vidya Kumarasamy

D Priya Kumari

Prabir Chaudhuri

Sumita Mohanthy

Debasish Jatua

Diederik Lohman

Joseph J Amon

Gayatri Palat

Affiliations

Soon will be listed here.

Abstract

Purpose: More than 1 million new occurrences of cancer are diagnosed in India annually. Among patients with cancer, pain is a common and persistent symptom of the disease and its treatment. However, few studies to date have evaluated the prevalence of pain and the adequacy of pain management in Indian hospitals. This cross-sectional study aimed to assess the prevalence and sociodemographic patterns of cancer pain and pain management among a sample of inpatients and newly registered outpatients at four large regional cancer centers in India.

Methods: A sample of 1,600 patients with cancer who were current inpatients or newly registered outpatients were recruited and administered a questionnaire that was based on the Brief Pain Inventory. The survey tool included questions on demographics, medical history, and extent of clinical pain experienced. In addition, a pain management index score was created to link the severity of cancer pain with medication prescribed to treat it.

Results: A total of 88% of patients reported pain in the past 7 days, and approximately 60% reported that their worst pain was severe. Several demographic and medical characteristics of the study population predicted severe pain, including the following: lower educational level, outpatient status, and debt incurred as a result of illness. A total of 67% of patients were inadequately treated with analgesics. Inadequate pain management was associated with both treatment hospital and patient type, and patients who reported debt as a result of their illness were more likely to have inadequate pain management.

Conclusion: A majority of Indian patients with cancer experience significant pain and receive inadequate pain management. Improvement of pain management for Indian patients with cancer is needed urgently.

Citing Articles

Talking morphine: Pain and prognosis in Indian cancer care.

Surawy-Stepney N Med Anthropol Q. 2024; 39(1):e12895.

PMID: 39427339 PMC: 11878334. DOI: 10.1111/maq.12895.

Realizing the Right to Health: A Long and Winding Road.

Amon J Health Hum Rights. 2023; 25(2):1-14.

PMID: 38145135 PMC: 10733759.

Views and experiences of opioid access amongst palliative care providers and public representatives in a low-resource setting: A qualitative interview study.

Clark J, Salins N, Daniel S, Currow D, Jones L, Pearson M PLOS Glob Public Health. 2023; 3(9):e0002401.

PMID: 37733698 PMC: 10513320. DOI: 10.1371/journal.pgph.0002401.

Willingness of patients with cancer pain to participate in end-of-life decisions: a multi-center cross-sectional study from three coastal provinces in southern China.

Ke X, Zhu H, Zhang Y, Yang L, Shi S, Zhu F BMC Palliat Care. 2022; 21(1):207.

PMID: 36434622 PMC: 9700943. DOI: 10.1186/s12904-022-01108-x.

Opioid Use Disorders among Patients on Long-Term Morphine for Management of Chronic Cancer Pain: A Pilot Study from a Tertiary Palliative Care Facility.

Choudhary N, Singh S, Rathore P, Ambekar A, Bhatnagar S Indian J Palliat Care. 2021; 27(2):264-268.

PMID: 34511794 PMC: 8428893. DOI: 10.25259/IJPC_358_20.

References

Rajagopal M, Joranson D, Gilson A . Medical use, misuse, and diversion of opioids in India. Lancet. 2001; 358(9276):139-43. DOI: 10.1016/s0140-6736(01)05322-3. View

Lohman D, Amon J . Evaluating a Human Rights-Based Advocacy Approach to Expanding Access to Pain Medicines and Palliative Care: Global Advocacy and Case Studies from India, Kenya, and Ukraine. Health Hum Rights. 2016; 17(2):149-65. View

Joranson D, Rajagopal M, Gilson A . Improving access to opioid analgesics for palliative care in India. J Pain Symptom Manage. 2002; 24(2):152-9. DOI: 10.1016/s0885-3924(02)00458-x. View

Saxena A, Mendoza T, Cleeland C . The assessment of cancer pain in north India: the validation of the Hindi Brief Pain Inventory--BPI-H. J Pain Symptom Manage. 1999; 17(1):27-41. DOI: 10.1016/s0885-3924(98)00104-3. View

Mallath M, Taylor D, Badwe R, Rath G, Shanta V, Pramesh C . The growing burden of cancer in India: epidemiology and social context. Lancet Oncol. 2014; 15(6):e205-12. DOI: 10.1016/S1470-2045(14)70115-9. View

Manjiani D, Paul D, Kunnumpurath S, Kaye A, Vadivelu N . Availability and utilization of opioids for pain management: global issues. Ochsner J. 2014; 14(2):208-15. PMC: 4052588. View

Rajagopal M, Joranson D . India: opioid availability. An update. J Pain Symptom Manage. 2007; 33(5):615-22. DOI: 10.1016/j.jpainsymman.2007.02.028. View

Zaza C, Baine N . Cancer pain and psychosocial factors: a critical review of the literature. J Pain Symptom Manage. 2003; 24(5):526-42. DOI: 10.1016/s0885-3924(02)00497-9. View

Lohman D, Schleifer R, Amon J . Access to pain treatment as a human right. BMC Med. 2010; 8:8. PMC: 2823656. DOI: 10.1186/1741-7015-8-8. View

10.

Larue F, Colleau S, Brasseur L, Cleeland C . Multicentre study of cancer pain and its treatment in France. BMJ. 1995; 310(6986):1034-7. PMC: 2549429. DOI: 10.1136/bmj.310.6986.1034. View

11.

Kumar S . Utilization of brief pain inventory as an assessment tool for pain in patients with cancer: a focused review. Indian J Palliat Care. 2011; 17(2):108-15. PMC: 3183599. DOI: 10.4103/0973-1075.84531. View

12.

Miranda J, Kinra S, Casas J, Davey Smith G, Ebrahim S . Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health. 2008; 13(10):1225-34. PMC: 2687091. DOI: 10.1111/j.1365-3156.2008.02116.x. View

13.

Serlin R, Mendoza T, Nakamura Y, Edwards K, Cleeland C . When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995; 61(2):277-284. DOI: 10.1016/0304-3959(94)00178-H. View

14.

Jadad A, Browman G . The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. JAMA. 1995; 274(23):1870-3. View

15.

Shipton E . The pain experience and sociocultural factors. N Z Med J. 2013; 126(1370):7-9. View

16.

Fisch M, Lee J, Weiss M, Wagner L, Chang V, Cella D . Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol. 2012; 30(16):1980-8. PMC: 3383175. DOI: 10.1200/JCO.2011.39.2381. View

17.

Cleeland C, GONIN R, Hatfield A, Edmonson J, Blum R, Stewart J . Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994; 330(9):592-6. DOI: 10.1056/NEJM199403033300902. View

18.

Koshy R, Rhodes D, Devi S, Grossman S . Cancer pain management in developing countries: a mosaic of complex issues resulting in inadequate analgesia. Support Care Cancer. 1998; 6(5):430-7. DOI: 10.1007/s005200050190. View

19.

. [A manifesto by physicians for Syria]. Rev Med Suisse. 2012; 8(344):1248-9. View

20.

van den Beuken-van Everdingen M, de Rijke J, Kessels A, Schouten H, van Kleef M, Patijn J . High prevalence of pain in patients with cancer in a large population-based study in The Netherlands. Pain. 2007; 132(3):312-320. DOI: 10.1016/j.pain.2007.08.022. View